ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IMM Immupharma Plc

2.075
0.00 (0.00%)
Last Updated: 08:51:30
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.075 2.05 2.09 - 50,825 08:51:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -1.82 6.9M
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 2.08p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares in issue. The market capitalisation of Immupharma is £6.90 million. Immupharma has a price to earnings ratio (PE ratio) of -1.82.

Immupharma Share Discussion Threads

Showing 35876 to 35895 of 39125 messages
Chat Pages: Latest  1445  1444  1443  1442  1441  1440  1439  1438  1437  1436  1435  1434  Older
DateSubjectAuthorDiscuss
21/2/2020
18:07
Thank you all.

I suspect you need a bit of an open mind to buy this again given many (like myself) will be have a ‘once bitten twice shy’ feeling about this. I did however top slice so didnt lose too much first time.

Biotechs are good since shifting my portfolio to more defensive shares as I think Corona effects wildly underestimated currently and market will topple.

gspanner
21/2/2020
17:22
The large trades at the end 3x50k ha given a new push to the share price and 4th day on the rise.
today 35K as UT at 16p

master rsi
21/2/2020
17:14
Great finish...
marie1980
21/2/2020
17:11
Yes welcome GSP to our forum ... .a time when things are getting exciting and optimistic year ahead
halfbutt
21/2/2020
16:27
Welcome gspanner...
marie1980
21/2/2020
14:25
Chart looking good
the stigologist
21/2/2020
13:54
Well I must say I never thought I would buy this one again... But a reasonably compelling story again and the tie up seems to mitigate for the large amount of cash needed to complete the studies required; Phoenix from the ashes and all that. Not for widows and orphans mind.
gspanner
20/2/2020
19:47
Fantastic job master 😍👌👍
marie1980
20/2/2020
16:58
Not much happening during much of the day, the volume was low but almost everywhere, but there was a change late in the afternoon and not only here but also with some other pharma shares where push higher on good demand. >>> Mereo Biopharma ( MPH), and NAHL Group ( NAH)



It seems that as the volume was so low the UT did not operate and a middle price was use as a closing price today 15.45p ( 15.20 v 15.70p ) good to see a high 15.98p "AT" earlier.

master rsi
20/2/2020
16:51
but still another blue day master :)
marie1980
20/2/2020
14:19
A day of no volume not only here but on all the Market in general, one of the lowest that I have seen for some time
master rsi
20/2/2020
14:15
. In parallel, we have entered into positive discussions with a number of potential commercial partners for Lupuzor™ outside of the US. We are in a new chapter within ImmuPharma's history, 
ntbb
20/2/2020
12:35
DNL first go for right issue and then sept binary fda approval

Stay away.

marie1980
20/2/2020
11:58
DNL about to explode , Institutional investor added 1 million shares this week . LOTS of BIG NEWS around the corner =10+ BAGGER GEM RALLLYYYYYYYYYYYY

Diurnal (DNL)
Market Cap £27 M
Price: 31p



Upcoming Catalysts:

MAA-Acceptance for Chronocort in February/March 2020

Alkindi approval in Israel expected in 2Q 2020

Alkindi approval in Australien expected in 2Q 2020

US-Partnership for Alkindi & Chronocort expected in 1H 2020

Alkindi & Chronocort Partnership for Asia für Japan und China

US-Approval for Alkindi expected in 4Q 2020

EU Approval for Chronocort expected in 4Q/1Q 2020/21


Investment summary:Alkindi, a cortisol replacement therapy designed for children under 18 years of age, is DNL’s first product on the market. It is expected to be followed by Chronocort for adults – a larger market – which now has a clear pathway for regulatory approval in both Europe and the US. Despite this, the share price is still languishing well below valuations determined by peer group and DCF (202p) analyses

bioking
19/2/2020
23:02
Though the trades were not there in the afternoon, the volume was the highest for the last 2 months

2 month chart with volume

master rsi
19/2/2020
13:06
Master,

I think all the buys has been so far absorbed by sell or vice-versa ? I can see this is huge volume and sells.

Data from H&L.


09:43 - 19/02 Sell 452695 15.50p £70,167.73
09:47 - 19/02 Sell 431653 15.00p £64,747.95
08:59 - 19/02 Buy 300000 14.60p £43,800.00
08:52 - 19/02 Sell 272381 14.50p £39,495.25
08:55 - 19/02 Sell 262536 14.50p £38,067.72

marie1980
19/2/2020
10:06
Nice one master.

Good to know: thank you for sharing: appreciate it.

marie1980
19/2/2020
09:53
Marie1980

The order book works the other way round
The "AT" sells are buys
The buying is place on the bid side and the selling on the offer side and when is done comes as an "AT".

master rsi
19/2/2020
09:48
ALERT

No one buys to drink Amaretto any more

No one listen to Amaretto RUBBISH talk any longer

maturo
19/2/2020
09:33
Some huge selling..

19-Feb-20 08:59:51 14.60 300,000 Sell* 43.80k A
19-Feb-20 08:59:04 14.50 37,464 Sell* 5,432 A
19-Feb-20 08:55:03 14.50 262,536 Sell* 38.07k A
19-Feb-20 08:55:03 14.50 27,619 Sell* 4,005 A
19-F

marie1980
Chat Pages: Latest  1445  1444  1443  1442  1441  1440  1439  1438  1437  1436  1435  1434  Older

Your Recent History

Delayed Upgrade Clock